“…The meningeal arachnoid barrier is a component of the blood-cerebrospinal fluid barrier (B-CSFB), that along with barriers at the pial vasculature and choroid plexus, regulates the free movement of molecules and cells into and out of the CSF in the subarachnoid space and ventricles (Balin et al, 1986; Ichikawa and Itoh, 2011; Ichikawa et al, 2010; Rodriguez-Peralta, 1957; Roth et al, 2013). A mechanistic understanding of how the blood-brain barrier (BBB) and B-CSFB develop and function is important, as their disruptions contribute to the pathophysiology of brain injury, neurodegenerative disorders, neuroinflammatory diseases, cancer, and the aged brain (Alves de Lima et al, 2020; Brkic et al, 2015; Derk et al, 2021; Iliff et al, 2012; Liebner et al, 2018; Sweeney et al, 2019). The arachnoid barrier separates the fenestrated blood vessels of the dura from the immune privileged CSF and is composed of epithelial-like cells connected by tight and adherens junctions (Nabeshima et al, 1975; Polanco et al, 2021; Rascher and Wolburg, 1997; Uchida et al, 2019).…”